Daunorubicin Metabolism in Leukemic Cells Isolated from Patients with Acute Myeloid Leukemia

Publisher： Bentham Science Publishers

E-ISSN： 1874-0758|4|4|228-232

ISSN： 1872-3128

Source： Drug Metabolism Letters, Vol.4, Iss.4, 2010-12, pp. : 228-232

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Idarubicin is superior to daunorubicin in remission induction of de novo acute myeloid leukemia patients with high MDR1 expression

By Shi Pengcheng   Zha Jie   Guo Xutao   Chen Feili   Fan Zhiping   Huang Fen   Meng Fanyi   Liu Xiaoli   Feng Ru   Xu Bing  

Pharmacogenomics, Vol. 14, Iss. 1, 2013-01 ,pp. : 17-23

Future Medicine

Access to resources Recommend Favorite

Acute Myeloid Leukemia

By  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 10, 2008-11 ,pp. : 962-962

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Pharmacogenomics in acute myeloid leukemia

By Roumier Christophe   Cheok Meyling H  

Pharmacogenomics, Vol. 10, Iss. 11, 2009-11 ,pp. : 1839-1851

Future Medicine

Access to resources Recommend Favorite

Immunotherapy in acute myeloid leukemia

By  

Cancer, Vol. 121, Iss. 16, 2015-08 ,pp. : 2689-2704

Blackwell Publishing

Access to resources Recommend Favorite

Immunotherapy of Acute Myeloid Leukemia

By  

Current Pharmaceutical Biotechnology, Vol. 2, Iss. 3, 2001-09 ,pp. : 209-215

Bentham Science Publishers

Access to resources Recommend Favorite